Jennifer Serriere-Di Bartolo holds a PhD in Structural Biology from the Institut de Biologie et Chimie des Protéines (CNRS, Lyon). She spent eight years at the SERVIER pharmaceutical group, first as a post-doctoral scientist in structural biology and then as Project Manager in Oncology and Biotechnologies, leading drug discovery programs from early research to preclinical stages.

She joined Promega as Head of Strategic Partnerships in France and has been leading strategic marketing for Drug Discovery Research for the past four years. Her work focuses on aligning bioassay technologies with pharmaceutical needs, including cell-based assays, immunoassays and potency assays supporting antibody discovery, mechanism-of-action studies, development and quality control, with increasing applications in veterinary biopharmaceutical research.